Cargando…

Overview of Neutralizing Antibodies and Their Potential in COVID-19

The antibody response to respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a major focus of COVID-19 research due to its clinical relevance and importance in vaccine and therapeutic development. Neutralizing antibody (NAb) evaluations are useful for the determination of individual or herd imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morales-Núñez, José Javier, Muñoz-Valle, José Francisco, Torres-Hernández, Paola Carolina, Hernández-Bello, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706198/ https://www.ncbi.nlm.nih.gov/pubmed/34960121 http://dx.doi.org/10.3390/vaccines9121376

Ejemplares similares

Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies
por: Morales-Núñez, José Javier, et al.
Publicado: (2022)

Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2
por: Hernández-Bello, Jorge, et al.
Publicado: (2021)

Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study
por: Morales-Núñez, José Javier, et al.
Publicado: (2022)

Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection
por: Morales-Núñez, José Javier, et al.
Publicado: (2021)

BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study
por: Hernández-Bello, Jorge, et al.
Publicado: (2023)

The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
por: Basile, Maria Sofia, et al.
Publicado: (2022)

A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
por: Sánchez-Zuno, Gabriela Athziri, et al.
Publicado: (2021)

Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review)
por: Turrubiates-Hernández, Francisco Javier, et al.
Publicado: (2021)

Severe COVID-19: Drugs and Clinical Trials
por: Ceja-Gálvez, Hazael Ramiro, et al.
Publicado: (2023)

Commentary: Long Non-Coding RNA Gene Polymorphisms and Their Expression Levels in Patients With Rheumatoid Arthritis
por: Hernández-Bello, Jorge, et al.
Publicado: (2021)

Vitamin D in Depression: A Potential Bioactive Agent to Reduce Suicide and Suicide Attempt Risk
por: Somoza-Moncada, María Montserrat, et al.
Publicado: (2023)

Metabolic syndrome in rheumatoid arthritis patients: Relationship among its clinical components
por: García‐Chagollán, Mariel, et al.
Publicado: (2020)

COVID-19 Screening by Anti-SARS-CoV-2 Antibody Seropositivity: Clinical and Epidemiological Characteristics, Comorbidities, and Food Intake Quality
por: Macedo-Ojeda, Gabriela, et al.
Publicado: (2021)

Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation
por: Sánchez-Zuno, Gabriela Athziri, et al.
Publicado: (2021)

Beamforming Techniques for Passive Radar: An Overview
por: Núñez-Ortuño, José M., et al.
Publicado: (2023)

Neutralizing Antibody Therapeutics for COVID-19
por: Hurt, Aeron C., et al.
Publicado: (2021)

Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes
por: Serna-Muñoz, Ricardo, et al.
Publicado: (2022)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

COVID-19 Antibody Tests: An Overview
por: Ravi, Arjun B., et al.
Publicado: (2021)

Modeling the COVID-19 pandemic: a primer and overview of mathematical epidemiology
por: Saldaña, Fernando, et al.
Publicado: (2021)

Association of extrapituitary prolactin promoter polymorphism with disease susceptibility and anti-RNP antibodies in Mexican patients with systemic lupus erythematosus
por: Hernández-Bello, Jorge, et al.
Publicado: (2016)

Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview
por: Ali, Manasik Gumah, et al.
Publicado: (2020)

Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
por: Valdez-Cruz, Norma A., et al.
Publicado: (2021)

An Overview of the Conventional and Novel Methods Employed for SARS-CoV-2 Neutralizing Antibody Measurement
por: Rocha, Vinícius Pinto Costa, et al.
Publicado: (2023)

Neutralizing antibody response in mild COVID-19
por: van der Heide, Verena
Publicado: (2020)

Neutralizing monoclonal antibodies for treatment of COVID-19
por: Taylor, Peter C., et al.
Publicado: (2021)

COVID-19 reinfection in the presence of neutralizing antibodies
por: Zhang, Ju, et al.
Publicado: (2021)

Neutralizing antibodies for the prevention and treatment of COVID-19
por: Du, Lanying, et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Broadly neutralizing antibodies against COVID-19
por: Zhou, Daming, et al.
Publicado: (2023)

A Novel Approach to Obtain Vaccine Effectiveness Continuous Profiles. Example Case: COVID-19 in Elderly Mexicans
por: González-Sánchez, Óscar A., et al.
Publicado: (2023)

Expression patterns of CD28 and CTLA‐4 in early, chronic, and untreated rheumatoid arthritis
por: García‐Chagollán, Mariel, et al.
Publicado: (2020)

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
por: Suthar, Mehul S., et al.
Publicado: (2020)

Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective
por: Ajmeriya, Swati, et al.
Publicado: (2022)

Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients
por: Giot, Matthieu, et al.
Publicado: (2021)

Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study
por: Muñoz-Valle, José Francisco, et al.
Publicado: (2022)

Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?
por: Morales-Torres, Jorge, et al.
Publicado: (2020)

COVID-19 vaccines: neutralizing antibodies and the alum advantage
por: Hotez, Peter J., et al.
Publicado: (2020)

Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
por: Zhou, Zeqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rq0v8489ol5njvds087llidsj9